April 19, 2025 a 12:00 pm
DXCM: Fundamental Ratio Analysis - DexCom, Inc.
DexCom, Inc. is a leading player in the continuous glucose monitoring system market. With its innovative products, the company has a strong foothold in diabetes management, providing real-time data solutions. Recent market movements and technological advancements make this stock an intriguing option for close observation.
Fundamental Rating
DexCom, Inc. has shown solid fundamental performance, reflected in its overall score of 3 out of 5. The rating category breakdown is as follows:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 1 | |
| Price To Earnings | 1 | |
| Price To Book | 1 |
Historical Rating
The historical rating provides insights into the changes in fundamental scores over time.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-04-17 | 3 | 3 | 5 | 5 | 1 | 1 | 1 |
| Previous | 0 | 3 | 5 | 5 | 1 | 1 | 1 |
Analyst Price Targets
The analyst price targets indicate a varied expectation with a high target of $146 and a low of $28.125, while the median target is $95.
| High | Low | Median | Consensus |
|---|---|---|---|
| $146 | $28.125 | $95 | $81.36 |
Analyst Sentiments
The majority of analysts are in favor of the stock, with a consensus rating of 'Buy'.
| Rating | Count | Distribution |
|---|---|---|
| Strong Buy | 1 | |
| Buy | 35 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
DexCom, Inc.'s continuous glucose monitoring technology offers significant potential, particularly given the rising prevalence of diabetes. While the fundamental ratings reveal robust returns, the stock carries valuation concerns as highlighted in the low price-to-earnings ratio. Analyst confidence, indicated by a consensus 'Buy' rating, suggests optimism despite these challenges. Investors should weigh the promising market prospects against current valuation metrics. Overall, DexCom remains a compelling investment, but prudent monitoring of market conditions is advised.